Toth Financial Advisory Corp Bio Xcel Therapeutics, Inc. Transaction History
Toth Financial Advisory Corp
- $774 Million
- Q2 2024
A detailed history of Toth Financial Advisory Corp transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Toth Financial Advisory Corp holds 500 shares of BTAI stock, worth $280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$280
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BTAI
# of Institutions
78Shares Held
7.26MCall Options Held
101KPut Options Held
205K-
Armistice Capital, LLC New York, NY2.99MShares$1.67 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA970KShares$543,4400.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$246,7830.0% of portfolio
-
Geode Capital Management, LLC Boston, MA267KShares$149,3620.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA204KShares$114,0240.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $15.7M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...